top of page
Organization name: AMD Therapeutics LLC (Delaware LLC)
R&D of new drug that is utilized existing or already marketed drug product by 505(b)2 path.
Support business for R&D activity and start-up company
Head office: Palo Alto, California (Oct 2022)
CEO & Founder: Hiroaki Serizawa, PhD
bottom of page